The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
- PMID: 35972143
- PMCID: PMC9600628
- DOI: 10.1128/mbio.01060-21
The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
Abstract
The COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus started its deadly journey into a global pandemic in Wuhan, China, in December 2019, where it was first isolated. Subsequently, multiple variants of the virus have been identified worldwide. In this review, we discuss the overall landscape of the pandemic in Mexico, including its most prevalent variants, their surveillance at a genomic level, and how they impacted the epidemiology of the disease. We also evaluate the heterologous vaccination in Mexico and how it may have influenced group immunity and helped mitigate the pandemic. Finally, we present an integrated view that could help us to understand the pandemic and serve as an example of the situation in Latin America.
Keywords: COVID-19 pandemic; SARS-CoV-2 variants; genomic vigilance; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Zhao H, Lu L, Peng Z, Chen L-L, Meng X, Zhang C, Ip JD, Chan W-M, Chu AW-H, Chan K-H, Jin D-Y, Chen H, Yuen K-Y, To KK-W. 2022. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect 11:277–283. doi: 10.1080/22221751.2021.2023329. - DOI - PMC - PubMed
-
- Romero Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, Gaona-Pineda EB, Martínez-Barnetche J, Alpuche-Aranda CM, Gómez-Acosta LM, Mendoza-Alvarado LR, Lazcano-Ponce E, Rivera-Dommarco J, Shamah-Levy T. 2021. Encuesta Nacional de Salud y Nutrición 2021 (Ensanut 2021). Salud Publica Mex 63:813–818. doi: 10.21149/13348. - DOI - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous